Summit Therapeutics SMMT Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's short-term investments?
- Summit Therapeutics (SMMT) reported short-term investments of $492.22M in Q1 2026.
- How has Summit Therapeutics's short-term investments changed year-over-year?
- Summit Therapeutics's short-term investments increased by 228.6% year-over-year, from $149.79M to $492.22M.
- What does short-term investments mean?
- Financial investments that are expected to be converted into cash within one year.
- How do you interpret short-term investments?
- An increase suggests efficient cash management of excess funds, while a decrease may indicate the liquidation of assets to fund operations.
- How does short-term investments compare across companies?
- Standard for companies with significant cash reserves seeking to generate yield on idle capital.